Purchase Order 75N91019P00292

<p>The National Cancer Institute awarded a purchase order to Atlanta Biologicals, Inc. for $33,494.70 on September 18, 2017, to acquire fetal bovine serum. Performance is scheduled to conclude by October 19, 2017, and will take place in Flowery Branch, Georgia. The order is priced on a firm fixed price basis with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Sigma-Aldrich, Inc. for fetal bovine serum with a ceiling value of $14,750.00 on August 22, 2019, with ultimate completion by September 22, 2019. Place of performance is Bethesda, Maryland. The order carries firm fixed-price pricing and no small-business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Atlanta Biologicals, Inc., valued at $15,823.40, on May 4, 2018, with completion on May 4, 2019. Work is performed in Flowery Branch, Georgia. Atlanta Biologicals, a subsidiary of Bio-Techne Corporation, supplies life sciences reagents and bioactive materials for research and diagnostic applications. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Atlanta Biologicals, Inc., valued at $9,999.72, on May 29, 2018, for firm fixed-price commercial biologics products. Place of performance is Flowery Branch, Georgia. The order was completed by May 28, 2019. No small business set-aside was used.</p>

<p>The National Cancer Institute issued a delivery order to Fisher Scientific Company L.L.C. on September 19, 2019, for fetal bovine serum (certified, United States Lot 2087367) with a ceiling value of $11,664.00.</p> <p>Place of performance is Pittsburgh, PA 15275. The order was priced on a firm fixed price basis and completed on September 28, 2019. This delivery order was issued under the GSA Multiple Award Schedule (Scientific Equipment and Services, FSS-66).</p>

<p>The National Cancer Institute awarded a purchase order to Atlanta Biologicals, Inc. for $11,320.32 on June 22, 2018, with an ultimate completion date of July 20, 2018. The order is firm fixed price with no set-aside. Work is performed in Bethesda, Maryland. Atlanta Biologicals is a child entity of Bio-Techne Corporation, a leading provider of life sciences tools and bioactive reagents including proteins, antibodies, and immunoassays for research and bioprocessing markets.</p>

<p>This is a $9,151.64 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Atlanta Biologicals Incorporated. The contract is for the purchase of fetal bovine serum (FBS). There is no set-aside designation indicated. The purchase order was awarded on July 22, 2014 with a completion date of July 27, 2014.</p>

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Atlanta Biologicals, Inc. for the procurement of 216 units of ATLANTA BIOLOGICALS INC FETAL BOVINE SERUM PREMIUM. The firm-fixed-price purchase order has a ceiling value of $70,125.30 and an ultimate completion date of April 21, 2017. The contract does not have a set-aside designation. Atlanta Biologicals, Inc. is a for-profit manufacturer of goods and a child...

The National Cancer Institute awarded a purchase order to Atlanta Biologicals, Inc. for $23,375.10 on July 17, 2018, with an ultimate completion date of August 16, 2018. The order was issued on a firm fixed-price basis with no set-aside applied. Work is performed at Bethesda, Maryland. Atlanta Biologicals is a subsidiary of Bio-Techne Corporation, a provider of life sciences tools and bioactive reagents including proteins, antibodies, immunoassays, and small molecules for research and diagnostic...

Atlanta Biologicals, Inc. was awarded a contract by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) for the supply of fetal bovine serum, a critical reagent used in biomedical research and cell culture applications. Executed as a Blanket Purchase Agreement (BPA) call on August 23, 2017, this firm fixed-price contract carried a ceiling value of $17,199.56 and was completed by November 30, 2017. The contract was performed at the awardee's facility in Flowery...